|
|
home > pmps > autumn 2003 > total supply chain solutions for the life sciences industry |
 |
 |
PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Let's begin by talking about the core services DHL provides to the life sciences industry.
DHL has been providing logistics solutions for the life sciences industry for many years. However, logistics is playing an ever greater role in this sector as companies seek to get closer to end-users and differentiate products through added value. As a result, in recent years DHL has been actively developing and refining customised services for the entire life sciences supply chain - from distribution consulting and design to management and execution.
Clinical trials, direct distribution programmes and cold chain services are some of the key focus areas for DHL. Our clinical trial services that offer distribution of clinical trial supplies, diagnostic specimen kits and case record forms, as well as the return of diagnostic specimens (using special IATA compliant collection kits) consigned to central laboratories for analysis. The life sciences industry is gradually moving towards various direct distribution models to improve integrity and stability of products in transit, while ensuring compliance, safety and customer satisfaction. DHL therefore has a range of direct distribution programmes for the delivery of pharmaceutical products, reagents and medical devices.
|
Read full article from PDF >>
|
 |
 |
 |
Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | |
|
|
 |
News and Press Releases |
 |
Quanticate Announces Plans to Accelerate Growth in North America
More info >> |
|

 |
White Papers |
 |
Quality By Design
Biopharma Group
Quality by Design (QbD) is a systematic approach to development that begins with the defined objectives and emphasizes science and quality risk management in order to achieve those goals. QbD ensures that the quality of the product is built into production processes from the outset, rather than being tested after development has already commenced.
More info >> |
|
|